A) Representative plots of Foxp3 in the spleens of the indicated T cell population. The average percentage of Foxp3+ cells in BALB/c mice: CD4+, inguinal LN = 10.9% +/− 2.3%, spleen = 6.8% +/− 2.6% (n=4); CD4+ B220+, inguinal LN = 12.0% +/− 3.0%, spleen = 12.1% +/− 1.7% (n=3). The average percentage of Foxp3+ cells in young lpr/lpr gld/gld mice: CD4+, inguinal LN = 11.9% +/− 6.4%, spleen = 18.0% +/− 5.0% (n=3–4); CD4+ B220+, inguinal LN = 4.0% +/− 1.6%, spleen = 3.9% +/− 0.8% (n=3). The average percentage of Foxp3+ cells in old lpr/lpr gld/gld mice: CD4+, inguinal LN = 14.7% +/− 3.7%, spleen = 25.8% +/− 5.0% (n=3–4); CD4+ B220+, inguinal LN = 1.1% +/− 0.5%, spleen = 2.5% +/− 0.7% (n=2–3). B) Absolute cell number of Foxp3+ and Foxp3− cells in the CD4+, CD4+ B220+, and DN T cell subsets (n=3). C) Foxp3 localization in the spleens of BALB/c and young and old lpr/lpr gld/gld mice (n≥3).